Sign inJoin waitlistJoin the waitlist

Albert Lai

Co-Chair, Protocol Review and Monitoring System · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · · ·

History

Protocol Review and Monitoring System Department · UCLA David Geffen School of Medicine/UCLA Medical Center
Present
UCLA David Geffen School of Medicine/UCLA Medical Center
Present
UCLA David Geffen School of Medicine/UCLA Medical Center
Present

UCLA David Geffen School of Medicine/UCLA Medical Center
2004–2005
Neurology
UCLA David Geffen School of Medicine/UCLA Medical Center
1999–2002
Internal Medicine
Adventist Health White Memorial
1998–1999
University of California at San Diego
UC San Diego School of Medicine
1994–1998

Research

Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma
PLoS Medicine · 2008 · 484 citations
Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome
Cell · 2018 · 409 citations
Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme
Journal of Clinical Oncology · 2011 · First of 20 authors · Corresponding · 377 citations

Timothy Cloughesy
162 papers
Leia Nghiemphu
128 papers · 2 as a fellow
Whitney Pope
90 papers
Linda Liau
86 papers
William Yong
38 papers
Noriko Salamon
37 papers
Paul Mischel
21 papers
Richard Everson
15 papers · 2 as a resident
Richard Green
15 papers
Harley Kornblum
12 papers
Stanley Nelson
12 papers
Kevin Leu
11 papers · 1 as a resident

Grants

Investigation of Tumor Suppressive miR-148a in IDH Mutant Gliomas
National Cancer Institute · R01
Contact PI · $1.6M · University of California Los Angeles
2014–2019
Genome-Wide Promoter Methylation Profiling of Glioma
National Cancer Institute · K08
Contact PI · $789.9K · University of California Los Angeles
2008–2013

Clinical trials

Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
2011–2018
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
2006–2015